Real-world safety experience with Peanut (Arachis hypogaea) Allergen Powder-dnfp in 2500 children with peanut allergy

被引:0
|
作者
Jara, Michele [1 ]
Walker, Ekaterina [1 ]
Tilles, Stephen [1 ]
Anagnostou, Aikaterini [2 ]
机构
[1] Nestle Hlth Sci Co, Aimmune Therapeut, Brisbane, CA 94005 USA
[2] Texas Childrens Hosp, Dept Pediat, Div Immunol Allergy & Retrovirol, Houston, TX USA
关键词
ORAL IMMUNOTHERAPY;
D O I
10.1016/j.anai.2024.02.027
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:778 / 780
页数:3
相关论文
共 41 条
  • [1] Real-world experience of pediatric patients treated with peanut (Arachis hypogaea) allergen powder-dnfp
    Portnoy, Jay
    Shroba, Jodi
    Tilles, Stephen
    Romdhani, Hela
    Donelson, Sarah M.
    Latremouille-Viau, Dominick
    Bungay, Rebecca
    Chen, Kathleen
    McCann, William
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 130 (05) : 649 - 656.e4
  • [2] PHYSICIAN EXPERIENCE WITH PRESCRIBING PEANUT (ARACHIS HYPOGAEA) ALLERGEN POWDER-DNFP IN PEDIATRIC PATIENTS WITH PEANUT ALLERGY
    Portnoy, J.
    Shroba, J.
    Tilles, S.
    Romdhani, H.
    Donelson, S.
    Latremouille-Viau, D.
    Bungay, R.
    Chen, K.
    Yassine, M.
    McCann, W.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S43 - S44
  • [3] Peanut (Arachis hypogaea) allergen powder-dnfp (Palforzia™) in peanut allergy: a profile of its use
    Heo, Young-A
    [J]. DRUGS & THERAPY PERSPECTIVES, 2021, 37 (11) : 495 - 502
  • [4] Peanut (Arachis hypogaea) allergen powder-dnfp (Palforzia™) in peanut allergy: a profile of its use
    Young-A Heo
    [J]. Drugs & Therapy Perspectives, 2021, 37 : 495 - 502
  • [5] Manufacturing processes of peanut (Arachis hypogaea) allergen powder-dnfp
    Leonard, Stephanie A.
    Ogawa, Yasushi
    Jedrzejewski, Paul T.
    Maleki, Soheila J.
    Chapman, Martin D.
    Tilles, Stephen A.
    Du Toit, George
    Mustafa, S. Shahzad
    Vickery, Brian P.
    [J]. FRONTIERS IN ALLERGY, 2022, 3
  • [6] Safety of peanut (Arachis hypogaea) allergen powder-dnfp in children and teenagers with peanut allergy: Pooled summary of phase 3 and extension trials
    Brown, Kari R.
    Baker, James
    Vereda, Andrea
    Beyer, Kirsten
    Burks, A. Wesley
    du Toit, George
    Hourihane, Jonathan O'b
    Jones, Stacie M.
    Norval, David
    Dana, Adrian
    Shreffler, Wayne
    Vickery, Brian P.
    Casale, Thomas
    Skeel, Ben
    Adelman, Daniel
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (06) : 2043 - +
  • [7] Peanut (Arachis hypogaea) Allergen Powder-dnfp Manufacturing Including Standardization Of Allergen Potency
    Tilles, Stephen
    Leonard, Stephanie
    Jedrzejewski, Paul
    Ogawa, Yasushi
    Maleki, Soheila
    Chapman, Martin
    Du Toit, George
    Mustafa, S. Shahzad
    Vickery, Brian
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB171 - AB171
  • [8] MANUFACTURING PROCESSES AND STANDARDIZATION OF ALLERGEN POTENCY OF PEANUT (ARACHIS HYPOGAEA) ALLERGEN POWDER-DNFP
    Tilles, S.
    Leonard, S.
    Jedrzejewski, P.
    Maleki, S.
    Chapman, M.
    DuToit, G.
    Mustafa, S.
    Vickery, B.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S59 - S59
  • [9] Peanut (Arachis hypogaea) allergen powder-dnfp for the mitigation of allergic reactions to peanuts in children and adolescents
    Casale, Thomas B.
    Irani, Anne-Marie
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (03) : 253 - 265
  • [10] Safety Of Peanut (Arachis hypogaea) Allergen Powder-dnfp Oral Immunotherapy In Individuals With Peanut Allergy Aged 1 To <4 Years (POSEIDON Trial)
    Du Toit, George
    Ratnayake, Anoshie
    Irani, Anne-Marie
    Norval, David
    Brown, Kari
    Vickery, Brian
    jones, Stacie
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB30 - AB30